American Well (NYSE:AMWL) Stock: Insider Phyllis Gotlib Sells 6,677 Shares

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 6,677 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total transaction of $86,801.00. Following the completion of the transaction, the insider owned 142,504 shares in the company, valued at approximately $1,852,552. This trade represents a 4.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Phyllis Gotlib also recently made the following trade(s):

• On Tuesday, September 1st, Phyllis Gotlib sold 3,573 shares of American Well stock. The shares were sold at an average price of $11.80, for a total transaction of $42,161.40.

American Well Trading Up 2.7%

Shares of NYSE:AMWL traded up $0.34 during trading on Monday, reaching $12.73. The company had a trading volume of 82,244 shares, compared to its average volume of 99,318. The company has a fifty day moving average of $12.54 and a two-hundred day moving average of $9.50. The stock has a market capitalization of $210.62 million, a P/E ratio of -2.67 and a beta of 1.67. American Well Corporation has a 12 month low of $3.71 and a 12 month high of $14.19.

American Well (NYSE:AMWL) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.27. American Well had a negative net margin of 35.75% and a negative return on equity of 30.12%. The company had revenue of $52.05 million during the quarter, compared to the consensus estimate of $49.87 million. As a group, equities research analysts predict that American Well Corporation will post -2.56 earnings per share for the current year.

Analyst Ratings Changes

AMWL has been the subject of several research analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of American Well in a research note on Friday, July 17th. Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Wednesday, August 5th. Truist Financial set a $12.00 price objective on American Well and gave the company a “hold” rating in a report on Thursday, August 13th. Finally, Wells Fargo & Company boosted their target price on American Well from $9.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $9.50.

Hedge Funds Weigh In On American Well

A hedge fund recently bought a new stake in American Well stock. Whetstone Capital Advisors LLC purchased a new position in American Well Corporation (NYSE:AMWL) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,000 shares of the company’s stock, valued at approximately $123,000. Whetstone Capital Advisors LLC owned about 0.15% of American Well as of its most recent SEC filing. 56.05% of the stock is owned by hedge funds and other institutional investors.

American Well Company Profile

American Well Corporation, doing business as Amwell, is a digital health company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care, specialty care and chronic-condition management.

Amwell also provides software and infrastructure that enable health systems, health plans, employers and government organizations to offer and manage digital healthcare programs.